Characterization of the 15kD - Selenoprotein by HPLC-ICP-MS

Trace Elements and Electrolytes

Volumn 27, Issue 3, 2010, Pages 145-149

  Bartel, J ^a   Bartz, T ^a   Schmidt, D ^a   Sote A ^a   Kyriakopoulos, A ^a  

^a HAHN MEITNER INSTITUT   (Germany)

Author keywords

15kD selenoprotein; HPLC ICP MS; Selenium; Selenopeptide

Indexed keywords

SELENIUM; SELENOPROTEIN;

ASSAY; CANCER CELL CULTURE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CYTOSOL; DIET; DISEASE COURSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROTEIN ANALYSIS; RAT;

RATTUS;

EID: 77953813313     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/tep27145     Document Type: Conference Paper

References (24)

1. Tarp U, Stengaard-Pedersen K, Hansen JC, Thorling EB. Glutathione redox cycle enzymes and selenium in severe rheumatoid arthritis: lack of antioxidative response to selenium supplementation in polymorphonuclear leucocytes. Ann Rheum Dis. 1992; 51: 1044-1049.
2. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal. 2007; 9: 775-806.
3. Haug A, Eich-Greatorex S, Bernhoft A, et al. Effect of dietary selenium and omega-3 fatty acids on muscle composition and quality in broilers. Lipids Health Dis. 2007; 6: 29.
4. Schafer K, Kyriakopoulos A, Gessner H, Grune T, Behne D. Effects of selenium deficiency on fatty acid metabolism in rats fed fish oil-enriched diets. J Trace Elem Med Biol. 2004; 18: 89-97. (Pubitemid 39307044)
5. Das A, Bortner J, Desai D, Amin S, El-Bayoumy K. The selenium analog of the chemopreventive compound S,S′-(1,4-phenylenebis[1,2-ethanediyl]) bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer. Chem Biol Interact. 2009; 180: 158-164.
6. Irons R, Carlson BA, Hatfield DL, Davis CD. Both selenoproteins and low molecular weight seleno-compounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr. 2006; 136: 1311-1317.
7. Diwadkar-Navsariwala V, Prins GS, Swanson SM, et al. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A. 2006; 103: 8179-8184. (Pubitemid 43801072)
8. Behne D, Hofer-Bosse T. Effects of a low selenium status on the distribution and retention of selenium in the rat. J Nutr. 1984; 114: 1289-1296. (Pubitemid 14081809)
9. Behne D, Hilmert H, Scheid S, Gessner H, ElgerW. Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim Biophys Acta. 1988; 966: 12-21.
10. Kryukov GV, Castellano S, Novoselov SV, et al. Characterization of mammalian selenoproteomes. Science. 2003; 300: 1439-1443.
11. Kalcklosch M, Kyriakopoulos A, Gessner H, Hammel C, Behne D. A new selenoprotein found in the glandular epithelial cells of the rat prostate. Biochem Biophys Res Commun. 1995; 217: 162-170. (Pubitemid 26004775)
12. Crawford ED. Epidemiology of prostate cancer. Urology. 2003; 62 (Suppl.): 3-12.
13. Behne D, Kyriakpoulos A,Weiss-Nowak C. Newly found selenium-containing proteins in the tissues of the rat. Biol Trace Element Res. 1996; 55: 110.
14. Hu YJ, Korotkov KV, Mehta R, et al. Distribution and functional consequences of nucleotide polymorphisms in the 3′-untranslated region of the human Sep15 gene. Cancer Res. 2001; 61: 2307-2310. (Pubitemid 32692064)
15. Starlard-Davenport A, Lyn-Cook B, Radominska-Pandya A. Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene. Steroids. 2008; 73: 139-147. (Pubitemid 350245675)
16. Starlard-Davenport A, Lyn-Cook B, Radominska-Pandya A. Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues. Steroid. 2008; 73: 611-620.
17. Peters U, Foster CB, Chatterjee N, et al. Serum selenium and risk of prostate cancer-a nested casecontrol study. Am J Clin Nutr. 2007; 85: 209-217.
18. Behne D, Kyriakopoulos A, Scheid S, Gessner H. Effects of chemical form and dosage on the incorporation of selenium into tissue proteins in rats. J Nutr. 1991; 121: 806-814.
19. Bartel J, Bartz T, Wolf C, et al. Activity of the glutathione peroxidase-2. Differences in the selenium-dependent expression between colon and small intestine. Cancer Genomics Pr. 2007; 4: 369-372.
20. Chambers I, Frampton J, Goldfarb P, Affara N, McBain W, Harrison PR. The structure of the mouse glutathione peroxidase gene: the selenocysteine in the active site is encoded by the "termination" codon, TGA. Embo J. 1986; 5: 1221-1227.
21. Zinoni F, Birkmann A, Leinfelder W, Bock A. Cotranslational insertion of selenocysteine into formate dehydrogenase from Escherichia coli directed by a UGA codon. Proc Natl Acad Sci U S A. 1987; 84: 3156-3160. (Pubitemid 17085363)
22. Lehmann U, Wienkoop S, Tschoep H, Weckwerth W. If the antibody fails - a mass western approach. Plant J. 2008; 55: 1039-1046.
23. Keshishian H, Addona T, Burgess M, et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics. 2009; 10: 2339-2349.
24. Yang X, Lazar IM. MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides. BMC Cancer. 2009; 9: 96.